The highest ranked consensus pathways for the cloperastine-ADPKD gene expression overlap were associated with amino acid metabolism, peroxisome proliferator-activator receptor (PPAR) signalling, nuclear factor κB (NF-κB) and nuclear receptors (Figure 2B). This evidence concerns the gene PPARA and autosomal dominant polycystic kidney disease.